Ear zaps could ease Parkinson's speech and movement woes

NCT ID NCT07588191

First seen Jun 10, 2026 · Last updated Jun 19, 2026 · Updated 2 times

Summary

This study tests whether a mild electrical pulse to the ear, combined with physical and speech therapy, can improve voice, swallowing, balance, and walking in people with Parkinson's disease. 46 participants will receive either active or sham stimulation during 12 sessions over 4 weeks, with follow-up at 8 weeks. The goal is to see if this non-invasive approach can ease common Parkinson's symptoms.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PARKINSON'S DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Association of Parkinson´s Disease Galicia- Coruña

    RECRUITING

    A Coruña, 15008, Spain

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

    Contact

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

transcutaneous electrical nerve stimulation (TENS) of the vagus nerve in the ear

What this could lead to

If it works, this could offer a non-drug way to ease speech, swallowing, and movement problems in Parkinson's disease.

What could go wrong

This is a small early-stage trial with only 46 people, so results may not apply widely. The effect may be small or not last beyond 8 weeks.

Conditions

The condition(s) this trial relates to.

communication disorder Cough Parkinson disease Sialorrhea Tremor voice disorders Xerostomia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.